Announcement • Jul 28
Paramount Cosmetics (India) Limited to Report Q1, 2027 Results on Aug 12, 2026 Paramount Cosmetics (India) Limited announced that they will report Q1, 2027 results on Aug 12, 2026 New Risk • Jul 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 45% per year over the past 5 years. Market cap is less than US$10m (₹165.1m market cap, or US$1.71m). Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Revenue is less than US$5m (₹214m revenue, or US$2.2m). Announcement • Jun 18
Paramount Cosmetics (India) Limited Announces Appointment of Prerna Jain as Whole-Time Company Secretary and Compliance Officer, Effective June 18, 2026 Paramount Cosmetics (India) Limited held its Board of Directors meeting on June 18, 2026 and considered and approved the appointment of Ms. Prerna Jain as Whole-Time Company Secretary and Compliance Officer of the Company on recommendation of Nomination and Remuneration committee with effect from June 18, 2026. Ms. Prerna Jain is an Associate Member of the Institute of Company Secretaries of India and having experience in the areas of corporate laws, secretarial compliance, corporate governance, regulatory affairs, and capital market regulations. She possesses extensive experience in handling compliance and regulatory matters pertaining to listed companies, including compliance with the provisions of the Companies Act, SEBI regulations, and corporate governance requirements. Her expertise encompasses SEBI (Listing Obligations and Disclosure Requirements) Regulations, ICDR Regulations, SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, SEBI (Prohibition of Insider Trading) Regulations, board and committee matters, investor relations, statutory filings, and regulatory reporting. She has also gained valuable exposure in the field of due diligence, regulatory compliance, documentation, and coordination in relation to public issues, rights issues, preferential issues, private placements, and other capital market transactions. She has experience in dealing with various intermediaries, stock exchanges, and regulatory authorities in connection with such assignments. Her professional expertise, sound knowledge of corporate and securities laws, and commitment to high standards of governance and compliance make her well-suited for the responsibilities entrusted to her. 
